EXPERIMENTAL THERAPIES IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA

被引：15

作者：

FOSS, FM ^{[1
]}

KUZEL, TM ^{[1
]}

机构：

[1] NORTHWESTERN UNIV,SCH MED,CHICAGO,IL

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1995年 / 9卷 / 05期

关键词：

D O I：

10.1016/S0889-8588(18)30063-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Although meaningful clinical responses have been demonstrated in cutaneous T-cell lymphoma using a number of therapeutic modalities, survival benefits have not been demonstrated for the majority of patients. Several novel therapies, including retinoids, purine analogs, biologic response modifiers, monoclonal antibodies, and fusion toxins have demonstrated activity and clinical promise in early studies.

引用

收藏

页码：1127 / &

相关论文

共 48 条

[1] INTERLEUKIN-2 RECEPTOR TARGETED CYTO-TOXICITY INTERLEUKIN-2 RECEPTOR MEDIATED ACTION OF A DIPHTHERIA-TOXIN RELATED INTERLEUKIN-2 FUSION PROTEIN [J].

BACHA, P ;

WILLIAMS, DP ;

WATERS, C ;

WILLIAMS, JM ;

MURPHY, JR ;

STROM, TB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) :612-622

[2] IMPACT OF INTERLEUKIN-2-RECEPTOR-TARGETED CYTOTOXINS ON A UNIQUE MODEL OF MURINE INTERLEUKIN-2-RECEPTOR-EXPRESSING MALIGNANCY [J].

BACHA, PA ;

FORTE, SE ;

MCCARTHY, DM ;

ESTIS, L ;

YAMADA, G ;

NICHOLS, JC .

INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (01) :96-101

[3] THYMOPENTIN IN SEZARY-SYNDROME [J].

BERNENGO, MG ;

APPINO, A ;

BERTERO, M ;

NOVELLI, M ;

FIERRO, MT ;

DOVEIL, GC ;

LISA, F .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (17) :1341-1346

[4] HIGH-INCIDENCE OF INFECTIONS AFTER 2-CHLORODEOXYADENOSINE (2-CDA) THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMAS AND CHRONIC AND ACUTE LEUKEMIAS [J].

BETTICHER, DC ;

FEY, MF ;

VONROHR, A ;

TOBLER, A ;

JENZER, H ;

GRATWOHL, A ;

LOHRI, A ;

PUGIN, P ;

HESS, U ;

PAGANI, O ;

ZULIAN, G ;

CERNY, T .

ANNALS OF ONCOLOGY, 1994, 5 (01) :57-64

[5]

BRAATHEN LR, 1989, J DERMATOL TREAT, V1, P29

[6]

CHATTERJEE M, 1993, ANN NY ACAD SCI, V690, P376

[7] NEUROTOXICITY OF PURINE ANALOGS - A REVIEW [J].

CHESON, BD ;

VENA, DA ;

FOSS, FM ;

SORENSEN, JM .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) :2216-2228

[8] TREATMENT OF CUTANEOUS T-CELL LYMPHOMA WITH A NEW AROMATIC RETINOID (RO 10-9359) [J].

CLAUDY, AL ;

DELOMIER, Y ;

HERMIER, C .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 1982, 273 (1-2) :37-42

[9]

CLAUDY AL, 1985, RETINOIDS NEW TRENDS, P335

[10] PHASE-II TRIAL OF PENTOSTATIN IN REFRACTORY LYMPHOMAS AND CUTANEOUS T-CELL DISEASE [J].

CUMMINGS, FJ ;

KIM, K ;

NEIMAN, RS ;

COMIS, RL ;

OKEN, MM ;

WEITZMAN, SA ;

MANN, RB ;

OCONNELL, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) :565-571

← 1 2 3 4 5 →